Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 6, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

625

[Prostate cryotherapy: General principles.]

Lucía Polanco Pujol1, Enrique Lledó García1, Jorge Caño Velasco1

  • 1Unidad de Andrología y Cirugía Reconstructiva Uretro-Genital. Servicio de Urología. Hospital General Universitario Gregorio Marañón. Madrid. España.

Archivos Espanoles De Urologia
|October 4, 2019
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting the Development of BCG-unresponsive Disease Among Patients with High-grade Non-muscle-invasive Bladder Cancer: An International Multicenter Analysis.

European urology oncology·2026
Same author

Current Evidence on the Use of Cystoscopy in the Follow-up of Non-Muscle-Invasive Bladder Cancer: Are We Overusing It? Systematic Review of the Literature.

Archivos espanoles de urologia·2026
Same author

Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer.

Future oncology (London, England)·2026
Same author

The impact of age in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin.

Urologic oncology·2026
Same author

Digital Uromonitor® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the 'External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the Club Urológico Español de Tratamiento Oncológico Group' (EVALUATION-CUETO) study.

BJU international·2026
Same author

Risk stratification of Ta high-grade non-muscle-invasive bladder cancer: Insights from a multicenter cohort study.

Urologic oncology·2026

Prostate cryotherapy is a safe and effective minimally invasive treatment for localized prostate cancer. While erectile dysfunction can occur, recurrence-free survival rates are high for low and intermediate-risk tumors.

Area of Science:

  • Urology
  • Oncology
  • Minimally Invasive Surgery

Background:

  • Prostate cryotherapy is an established minimally invasive treatment option.
  • It offers an alternative to traditional prostate cancer therapies.

Purpose of the Study:

  • To review the historical development, mechanism of action, and surgical techniques of prostate cryotherapy.
  • To evaluate oncological outcomes for primary, salvage, and focal cryotherapy, despite a lack of randomized trials.

Main Methods:

  • Review of historical development and surgical techniques.
  • Analysis of oncological results from retrospective studies and clinical trials.
  • Evaluation of recurrence-free survival rates for different risk groups and treatment modalities.
Keywords:
CrioterapiaCryotherapyCáncer próstataProstate cancerTratamientoTreatment

More Related Videos

Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

8.4K
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.4K

Related Experiment Videos

Last Updated: Jan 6, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

625
Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

8.4K
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.4K

Main Results:

  • Cryotherapy is a safe technique with a low complication rate, though erectile dysfunction incidence ranges from 40-90% with full-gland treatment.
  • Recurrence-free survival is approximately 96% for low-risk and 90% for intermediate-risk localized prostate cancer.
  • Focal cryoablation shows promising results with a 75% recurrence-free survival rate.

Conclusions:

  • Retrospective data suggest prostate cryotherapy is a safe and effective treatment for localized prostate cancer.
  • Further randomized studies are needed to provide more definitive scientific evidence.
  • Cryotherapy is a viable option for localized prostate cancer and salvage treatment after radiotherapy.